A2m is in a consolation phase. With the huge path to market and marketing strategies, the opportunities in tier 2,3,4 and beyond will be enormous.
- Forums
- ASX - By Stock
- A2M
- A2 Analyst Valuations
A2 Analyst Valuations, page-22
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
|
|||||
Last
$6.81 |
Change
-0.040(0.58%) |
Mkt cap ! $4.937B |
Open | High | Low | Value | Volume |
$6.88 | $6.90 | $6.81 | $1.650M | 241.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
25 | 16850 | $6.80 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.81 | 4467 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 4651 | 6.810 |
15 | 16028 | 6.800 |
17 | 32866 | 6.790 |
7 | 21287 | 6.780 |
6 | 6548 | 6.770 |
Price($) | Vol. | No. |
---|---|---|
6.820 | 7467 | 10 |
6.830 | 17987 | 14 |
6.840 | 27005 | 13 |
6.850 | 27360 | 15 |
6.860 | 31312 | 12 |
Last trade - 11.13am 16/07/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online